More pronounced decreases were observed for IL-3 and IL-6, both key regulators of hematopoietic proliferation and inflammatory skewing in MDS, with levels dropping to 82.13 ± 1.02 to 25.65 ± 0.68 and 79.52 ± 1.31 to 34.22 ± 0.57 MFI respectively (p < 0.0001). Here, IL3 is linked to myelodysplastic syndrome.